Megatas Plus 25mg Combikit Tablet 1's

Megatas Plus 25mg Combikit Tablet is a combination medicine used to treat overactive bladder (OAB) with symptoms of urinary incontinence (urine leakage), urgent or frequent urination, increased night-time urination, and dysuria (painful or difficult urination).

Megatas Plus 25mg Combikit Tablet contains Solifenacin and Mirabegron. Solifenacin reduces the undesirable contractions of the bladder, thereby increasing the amount of urine that the bladder can hold. Mirabegron relaxes the muscles of the bladder; this prevents symptoms of an overactive bladder.

Megatas Plus 25mg Combikit Tablet may cause side effects such as dry mouth, constipation, headache, high blood pressure, and vomiting. Most of these side effects do not require medical attention and resolve over time. However, talk to your doctor if any side effects persist or worsen.

Consult your doctor if you are pregnant or breastfeeding. Megatas Plus 25mg Combikit Tablet is not recommended for children. Inform your doctor about your health condition and medications to rule out any side effects/interactions.

Megatas Plus 25mg Combikit Tablet is used in the treatment of Overactive bladder. The detailed uses of Megatas Plus 25mg Combikit Tablet are as follows:

• Treating overactive bladder (OAB): Megatas Plus 25mg Combikit Tablet helps manage symptoms like urinary urgency, frequency, and urge incontinence by relaxing bladder muscles and reducing involuntary contractions.
• Enhancing bladder control and urine-holding capacity: Megatas Plus 25mg Combikit Tablet combines Mirabegron, which relaxes bladder muscles to increase storage volume, and Solifenacin, which prevents spasms by blocking muscarinic receptors, together improving continence and reducing urgency.
• Reducing nighttime urination and leakage: Megatas Plus 25mg Combikit Tablet is effective in lowering episodes of nocturia and accidental urine leakage, improving sleep and quality of life.

• Megatas Plus 25mg Combikit Tablet can be taken with or without food, as advised by your doctor.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Swallow Megatas Plus 25mg Combikit Tablet as a whole with a glass of water.
• Do not crush, chew, or break it.

• Megatas Plus 25mg Combikit Tablet is a combination of Solifenacin and Mirabegron, used to effectively manage symptoms of an overactive bladder (OAB).
• It treats symptoms such as urinary incontinence (urine leakage), urgent or frequent urination, increased night-time urination, and painful or difficult urination (dysuria).
• Solifenacin is an anticholinergic agent which reduces involuntary bladder contractions and increases bladder capacity.
• It allows the bladder to hold more urine and helps reduce the sudden urge to urinate.
• Mirabegron is a beta-3 adrenergic agonist which relaxes bladder muscles for improved control. It prevents frequent, urgent, or uncontrolled urination.
• Megatas Plus 25mg Combikit Tablet improves bladder control and urinary flow, reduces episodes of urine leakage and enhances overall comfort and quality of life in individuals with overactive bladder.

• Do not take Megatas Plus 25mg Combikit Tablet if you are allergic to any of its contents.
• Inform your doctor if you have glaucoma, myasthenia gravis, ulcerative colitis, urinary retention, high blood pressure, angioedema, kidney or liver problems.
• Consult your doctor if you are pregnant or breastfeeding.
• Megatas Plus 25mg Combikit Tablet is not recommended for children.
• Megatas Plus 25mg Combikit Tablet may cause blurred vision, so drive with caution.
• Avoid or limit alcohol consumption with Megatas Plus 25mg Combikit Tablet as it could lead to increased dizziness.
• Let your doctor know if you are taking any other medicines, including supplements and herbal products.